Why Beacon?
Discover how Beacon Oncology enables data-driven insight that will accelerate your Oncology drug development decisions.
- Validate Oncology asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore Oncology drug design strategies from therapeutic class and approved disease indications to emerging target investigations
- Benchmark your research with validated preclinical data, including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
- Find the right partners in a competitive market, by tracking new companies, collaborations, and licensing deals, as they emerge
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.
Request Beacon Oncology Demonstration
Please submit the form below to request your personalized demonstration of the Beacon Oncology platform. A member of our specialized team will be in touch shortly to schedule a time that suits you.
How is Beacon Oncology Different?
- A Unique Oncology Dataset: Comprehensive & accurate, preclinical and clinical, Oncology drug, trial and commercial data to inform your Oncology drug development decisions
- In Depth Preclinical Data: Including preclinical publication summaries, and links to conference abstracts and posters
- Proprietary Ontologies: Market leading standardized ontologies, enabling you to easily segment the Oncology drug development landscape, to quickly find the data that matters to you
- Human Intelligence: Beacon Oncology data is manually curated by sector specialist analysts, to ensure data accuracy and integrity
Search